Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| |
Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT.
JE Allison, Gastroenterology. 2005 Aug:745-8 |
| |
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.
CE Desch, AB Benson 3rd, MR Somerfield, PJ Flynn, C Krause, CL Loprinzi, BD Minsky, DG Pfister, KS Virgo, NJ Petrelli, American Society of Clinical Oncology, J Clin Oncol. 2005 Nov 20:8512-9 |
| |
Transanal endoscopic microsurgery: where are we now?
S Maslekar, DL Beral, TJ White, SH Pillinger, JR Monson, Dig Surg. 2006:12-22 |
| |
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
T Morikawa, J Kato, Y Yamaji, R Wada, T Mitsushima, Y Shiratori, Gastroenterology. 2005 Aug:422-8 |
| |
AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies.
CR Regueiro, AGA Future Trends Committee, Gastroenterology. 2005 Sep:1083-103 |
| |
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
H Hampel, JA Stephens, E Pukkala, R Sankila, LA Aaltonen, JP Mecklin, A de la Chapelle, Gastroenterology. 2005 Aug:415-21 |
| |
Colon cancer screening in 2005: status and challenges.
DF Ransohoff, Gastroenterology. 2005 May:1685-95 |
| |
Colonoscopy capacity: Can we build it? Will they come?
TR Levin, Gastroenterology. 2004 Dec:1841-4 |
| |
Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.
J Regula, M Rupinski, E Kraszewska, M Polkowski, J Pachlewski, J Orlowska, MP Nowacki, E Butruk, N Engl J Med. 2006 Nov 2:1863-72 |
| |
Colorectal cancer at a young age.
JP Terdiman, Gastroenterology. 2005 Apr:1067-76 |
| |
Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer.
C Lackner, G Hoefler, Eur J Gastroenterol Hepatol. 2005 Mar:317-22 |
| |
Genetic testing for inherited colon cancer.
R Burt, DW Neklason, Gastroenterology. 2005 May:1696-716 |
| |
Increased risk of rectal cancer after prostate radiation: a population-based study.
NN Baxter, JE Tepper, SB Durham, DA Rothenberger, BA Virnig, Gastroenterology. 2005 Apr:819-24 |
| |
Initial experience with a general population colorectal cancer screening clinic.
D Brosseuk, J Oosthuizen, M Pinchbeck, Am J Surg. 2006 May:669-72 |
| |
Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
PA Bampton, JJ Sandford, SR Cole, A Smith, J Morcom, B Cadd, GP Young, Gut. 2005 Jun:803-6 |
| |
It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population.
JP Terdiman, Gastroenterology. 2005 Aug:741-4 |
| |
Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.
FS Velayos, BA Allen, PG Conrad, J Gum Jr, S Kakar, DC Chung, B Truta, MH Sleisenger, YS Kim, JP Terdiman, Am J Gastroenterol. 2005 May:1143-9 |
| |
Mass screening with CT colonography: should the radiation exposure be of concern?
DJ Brenner, MA Georgsson, Gastroenterology. 2005 Jul:328-37 |
| |
Narrative review: screening for colorectal cancer in patients with a first-degree relative with colonic neoplasia.
GM Eisen, DS Weinberg, Ann Intern Med. 2005 Aug 2:190-8 |
| |
Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
D Heresbach, S Manfredi, PN D'halluin, JF Bretagne, B Branger, Eur J Gastroenterol Hepatol. 2006 Apr:427-33 |
| |
Screening and prevention of carcinoma of the colon and rectum
C Weber, Ther Umsch. 2006 May:333-7 |
| |
Screening for colorectal cancer in average-risk populations.
D Lieberman, Am J Med. 2006 Sep:728-35 |
| |
Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.
EY Chiao, TP Giordano, JM Palefsky, S Tyring, H El Serag, Clin Infect Dis. 2006 Jul 15:223-33 |
| |
Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.
PM Johnson, S Gallinger, RS McLeod, Dis Colon Rectum. 2006 Jan:80-93; discussion 94-5 |
| |
Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up.
PW Child, TD Yan, DS Perera, DL Morris, Dis Colon Rectum. 2005 Apr:744-8 |
| |
The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.
CP Gross, GJ McAvay, HM Krumholz, AD Paltiel, D Bhasin, ME Tinetti, Ann Intern Med. 2006 Nov 7:646-53 |
| |
The utility of capsule endoscopy small bowel surveillance in patients with polyposis.
CA Burke, J Santisi, J Church, G Levinthal, Am J Gastroenterol. 2005 Jul:1498-502 |
| |
What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation.
S Walleser, A Griffiths, SJ Lord, K Howard, MJ Solomon, V Gebski, Clin Gastroenterol Hepatol. 2007 Dec:1439-46; quiz 1368 |
| |
Will a 5-ASA a day keep the cancer (and dysplasia) away?
DT Rubin, BA Lashner, Am J Gastroenterol. 2005 Jun:1354-6 |
| |
Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
JA Fisher, C Fikry, AB Troxel, Cancer Epidemiol Biomarkers Prev. 2006 Jan:108-13 |
| |
Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data.
P Moayyedi, E Achkar, Am J Gastroenterol. 2006 Feb:380-4 |
| |
Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review.
SD Saini, HM Kim, P Schoenfeld, Gastrointest Endosc. 2006 Oct:614-26 |
| Supplementary evidence: |
| |
A survey of women regarding factors affecting colorectal cancer screening compliance.
DS Weinberg, BJ Turner, H Wang, RE Myers, S Miller, Prev Med. 2004 Jun:669-75 |
| |
AGA future trends report: CT colonography.
J van Dam, P Cotton, CD Johnson, BG McFarland, BC Pineau, D Provenzale, D Ransohoff, D Rex, D Rockey, FT Wootton 3rd, American Gastroenterological Association, Gastroenterology. 2004 Sep:970-84 |
| |
Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection.
AJ Clark, D Stockton, A Elder, RG Wilson, MG Dunlop, Br J Surg. 2004 Oct:1345-51 |
| |
Behavioral associations between prostate and colon cancer screening.
RC Carlos, W Underwood 3rd, AM Fendrick, SJ Bernstein, J Am Coll Surg. 2005 Feb:216-23 |
| |
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.
MD Rutter, BP Saunders, KH Wilkinson, S Rumbles, G Schofield, MA Kamm, CB Williams, AB Price, IC Talbot, A Forbes, Gut. 2004 Dec:1813-6 |
| |
Colon cancer screening in African American women.
D Frank, J Swedmark, L Grubbs, ABNF J. 2004 Jul-Aug:67-70 |
| |
Colon polyps and cancer.
O Kronborg, Endoscopy. 2004 Jan:3-7 |
| |
Colorectal cancer screening adherence in a general population.
MW Yeazel, TR Church, RM Jones, LK Kochevar, GD Watt, JE Cordes, D Engelhard, SJ Mongin, Cancer Epidemiol Biomarkers Prev. 2004 Apr:654-7 |
| |
Colorectal cancer screening and treatment: review of outcomes research.
D Provenzale, RN Gray, J Natl Cancer Inst Monogr. 2004:45-55 |
| |
Colorectal cancer screening in Australia: an economic evaluation of a potential biennial screening program using faecal occult blood tests.
CA Stone, RC Carter, T Vos, JS John, Aust N Z J Public Health. 2004 Jun:273-82 |
| |
Colorectal cancer screening: a review of the evidence.
SM Mahon, Clin J Oncol Nurs. 2004 Oct:536-40 |
| |
Colorectal cancer screening: prospects for molecular stool analysis.
RJ Davies, R Miller, N Coleman, Nat Rev Cancer. 2005 Mar:199-209 |
| |
Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?
U Ladabaum, K Song, AM Fendrick, Clin Gastroenterol Hepatol. 2004 Jul:554-63 |
| |
Community-based cancer screening programs in older populations: making progress but can we do better?
B Curbow, J Bowie, MA Garza, K McDonnell, LB Scott, CA Coyne, T Chiappelli, Prev Med. 2004 Jun:676-93 |
| |
Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo.
R Kiesslich, J Burg, M Vieth, J Gnaendiger, M Enders, P Delaney, A Polglase, W McLaren, D Janell, S Thomas, B Nafe, PR Galle, MF Neurath, Gastroenterology. 2004 Sep:706-13 |
| |
Cost effectiveness of a new strategy to identify HNPCC patients.
W Kievit, JH de Bruin, EM Adang, JL Severens, JH Kleibeuker, RH Sijmons, TJ Ruers, FM Nagengast, HF Vasen, JH van Krieken, MJ Ligtenberg, N Hoogerbrugge, Gut. 2005 Jan:97-102 |
| |
Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.
C Lejeune, P Arveux, V Dancourt, S Béjean, C Bonithon-Kopp, J Faivre, Int J Technol Assess Health Care. 2004 Fall:434-9 |
| |
CRC screening: review of the evidence and suggestions on when and how to move on from randomized trials to screening programmes.
G Hoff, Scand J Gastroenterol. 2004 Feb:99-103 |
| |
Current and future trends in colorectal cancer screening.
CJ Kahi, DK Rex, Cancer Metastasis Rev. 2004 Jan-Jun:137-44 |
| |
DNA-analysis in hereditary cancer: the importance of a reliable family history
S Kapma, NJ Leschot, CM Aalfs, Ned Tijdschr Geneeskd. 2005 Jan 8:57-60 |
| |
Effectiveness and patient tolerance of screening colonoscopy -- first results
D Huppe, L Lemberg, G Felten, Z Gastroenterol. 2004 Jul:591-8 |
| |
Evidence of the effectiveness of endoscopic screening for colorectal cancer among residents of Rhode Island, 1988-2002.
JP Fulton, K Koegel, D Darcy, Med Health R I. 2004 Oct:316-8 |
| |
Factors associated with colorectal cancer screening among Chinese-Americans.
WY Sun, CE Basch, RL Wolf, XJ Li, Prev Med. 2004 Aug:323-9 |
| |
Factors associated with intentions for colorectal cancer screenings in a Chinese sample.
SI Hou, Psychol Rep. 2005 Feb:159-62 |
| |
Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study
M Naumann, B Schaum, GM Oremek, E Hanisch, W R&oeig;sch, J M&oeig;ssner, WF Caspary, J Stein, Dtsch Med Wochenschr. 2004 Aug 20:1806-7 |
| |
Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.
PD Hardt, S Mazurek, M Toepler, P Schlierbach, RG Bretzel, E Eigenbrodt, HU Kloer, Br J Cancer. 2004 Aug 31:980-4 |
| |
Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
K Song, AM Fendrick, U Ladabaum, Gastroenterology. 2004 May:1270-9 |
| |
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
TF Imperiale, DF Ransohoff, SH Itzkowitz, BA Turnbull, ME Ross, Colorectal Cancer Study Group, N Engl J Med. 2004 Dec 23:2704-14 |
| |
Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance?
MJ O'brien, SJ Winawer, AG Zauber, MT Bushey, SS Sternberg, LS Gottlieb, JH Bond, JD Waye, M Schapiro, National Polyp Study Workgroup, Clin Gastroenterol Hepatol. 2004 Oct:905-11 |
| |
How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.
LC Seeff, TB Richards, JA Shapiro, MR Nadel, DL Manninen, LS Given, FB Dong, LD Winges, MT McKenna, Gastroenterology. 2004 Dec:1670-7 |
| |
How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment.
I Vogelaar, M van Ballegooijen, D Schrag, R Boer, SJ Winawer, JD Habbema, AG Zauber, Cancer. 2006 Oct 1:1624-33 |
| |
Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
HT Lynch, RE Brand, GY Locker, Fam Cancer. 2004:229-32 |
| |
Influences on participation in a community-based colorectal neoplasia screening program by virtual colonoscopy in Australia.
GM Forbes, L Fritschi, RM Mendelson, NM Foster, JT Edwards, Aust N Z J Public Health. 2004 Jun:283-7 |
| |
Institutional commitment to rectal cancer screening results in earlier-stage cancers on diagnosis.
AC Battat, RV Rouse, L Dempsey, BY Safadi, SM Wren, Ann Surg Oncol. 2004 Nov:970-6 |
| |
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
LC Seeff, DL Manninen, FB Dong, SK Chattopadhyay, MR Nadel, FK Tangka, NA Molinari, Gastroenterology. 2004 Dec:1661-9 |
| |
Meat consumption and risk of colorectal cancer.
A Chao, MJ Thun, CJ Connell, ML McCullough, EJ Jacobs, WD Flanders, C Rodriguez, R Sinha, EE Calle, JAMA. 2005 Jan 12:172-82 |
| |
Minnesota Colorectal Cancer Initiative: successful development and implementation of a community-based colorectal cancer registry.
DA Rothenberger, DL Dalberg, A Leininger, Dis Colon Rectum. 2004 Oct:1571-7 |
| |
Missing colorectal cancer.
B Rembacken, Endoscopy. 2004 Jun:551-3 |
| |
Overweight, obesity, and colorectal cancer screening: disparity between men and women.
M Heo, DB Allison, KR Fontaine, BMC Public Health. 2004 Nov 8:53 |
| |
Patient and provider barriers to colorectal cancer screening in the primary care safety-net.
AS O'Malley, E Beaton, KR Yabroff, R Abramson, J Mandelblatt, Prev Med. 2004 Jul:56-63 |
| |
Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review.
A Ferrández, W Samowitz, JA DiSario, RW Burt, Am J Gastroenterol. 2004 Oct:2012-8 |
| |
PRO: Endoscopic surveillance minimizes the risk of cancer.
W Connell, Am J Gastroenterol. 2004 Sep:1631-3 |
| |
Progression rates of colorectal cancer by Dukes' stage in a high-risk group: analysis of selective colorectal cancer screening.
JM Wong, MF Yen, MS Lai, SW Duffy, RA Smith, TH Chen, Cancer J. 2004 May-Jun:160-9 |
| |
Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States.
S Vijan, J Inadomi, RA Hayward, TP Hofer, AM Fendrick, Aliment Pharmacol Ther. 2004 Sep 1:507-15 |
| |
Prospective evaluation of screening colonoscopy: who is being screened?
B Bressler, C Lo, J Amar, S Whittaker, H Chaun, L Halparin, R Enns, Gastrointest Endosc. 2004 Dec:921-6 |
| |
Public awareness of risk factors and screening for colorectal cancer in Europe.
MR Keighley, C O'Morain, A Giacosa, M Ashorn, A Burroughs, M Crespi, M Delvaux, J Faivre, F Hagenmuller, V Lamy, F Manger, HT Mills, C Neumann, A Nowak, A Pehrsson, S Smits, K Spencer, United European Gastroenterology Federation Public Affairs Committee, Eur J Cancer Prev. 2004 Aug:257-62 |
| |
Racial/ethnic differences in screening for colon cancer: report from the New York Cancer Project.
D Vlahov, J Ahern, T Vazquez, S Johnson, LA Philips, D Nash, MK Mitchell, H Freeman, Ethn Dis. 2005 Winter:76-83 |
| |
Receipt of colorectal testing prior to colorectal carcinoma diagnosis.
GS Cooper, JD Payes, Cancer. 2005 Feb 15:696-701 |
| |
Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom.
UK Colorectal Cancer Screening Pilot Group, BMJ. 2004 Jul 17:133 |
| |
Review article: balancing the ideal versus the practical-considerations of colorectal cancer prevention and screening.
DA Lieberman, W Atkin, Aliment Pharmacol Ther. 2004 Feb:71-6 |
| |
Review article: chemoprevention of colorectal cancer.
ED Courtney, DM Melville, RJ Leicester, Aliment Pharmacol Ther. 2004 Jan 1:1-24 |
| |
Screening behavior of individuals at high risk for colorectal cancer.
EM Bleiker, FH Menko, BG Taal, I Kluijt, LD Wever, MA Gerritsma, HF Vasen, NK Aaronson, Gastroenterology. 2005 Feb:280-7 |
| |
Screening for colorectal cancer--now and the near future.
MQ Bromer, DS Weinberg, Semin Oncol. 2005 Feb:3-10 |
| |
Screening for colorectal cancer.
P Lau, J Sung, Chin J Dig Dis. 2004:87-92 |
| |
Screening for colorectal cancer: good, but not perfect.
M Pignone, Gastroenterology. 2004 Sep:989-90 |
| |
Screening of patients at average risk for colon cancer.
JS Mandel, Med Clin North Am. 2005 Jan:43-59, vii |
| |
Survey of surgeons' and internists' knowledge of colorectal cancer screening.
Y Niv, G Niv, Cancer Detect Prev. 2004:340-4 |
| |
The evolution to stool DNA testing for colorectal cancer.
KS Tagore, TR Levin, MJ Lawson, Aliment Pharmacol Ther. 2004 Jun 15:1225-33 |
| |
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.
VP Doria-Rose, TR Levin, JV Selby, PA Newcomb, KE Richert-Boe, NS Weiss, Gastroenterology. 2004 Sep:714-22 |
| |
The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer
K Takahashi, T Mori, T Yamaguchi, H Matsumoto, H Miyamoto, K Arai, Y Iwasaki, S Katayanagi, Gan To Kagaku Ryoho. 2004 Dec:154-6 |
| |
Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations.
M Barchana, I Liphshitz, P Rozen, Fam Cancer. 2004:207-14 |